Tumor-associated peritumoral lymphatics showed dramatic morphological differences across treatment conditions; lymphatic vessels from 4T1 mice treated with docetaxel appeared larger compared to control IgG-treated mice, and this size increase was mitigated by anti-VEGFR3 therapy (Fig. 4). Here, FLT4 is linked to neoplasm.